Clinical Trial Update: Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT [Phase 1, Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 1/2 trial evaluating a TCR alpha-beta depleted graft in pediatric patients with acute lymphoblastic leukemia or a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• TCR alpha-beta depleted graft (TCR alpha-beta depleted graft)

Snippet

Sponsor: Mariella Enoc | Conditions: Acute Lymphoblastic Leukemia, Leukemia Acute Myeloid - AML | Phase 1, Phase 2 | Status: COMPLETED